Search - tctmd.com

Displaying 621 - 640 of 712

Sort: Relevancy | Date

News Daily News

Among Younger Patients, Women More Likely Than Men to Be Readmitted After Acute MI

June 26, 2015

News Industry News

Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients

May 07, 2015

News Daily News

Study Highlights Discrepancies in STEMI Recognition, Care Between Young Men, Women

Yael L. Maxwell

April 29, 2015

News Daily News

Study Quantifies Costs Arising From Thrombotic Events During PCI for NSTE-ACS

Caitlin E. Cox

April 09, 2015

News Daily News

BRIGHT Published: Prolonged Bivalirudin Reduces Bleeding, Tames Early Stent Thrombosis in Primary PCI

April 03, 2015

News Daily News

Public Reporting Linked to Less PCI, Higher Mortality in Acute MI Patients

April 03, 2015

News Conference News ACC 2015

MATRIX Provides Support for Radial Access, Mixed Results for Bivalirudin

Todd Neale

March 17, 2015

News Daily News

VELOCITY Published: Peritoneal Cooling Does Not Decrease Infarct Size in STEMI

Yael L. Maxwell

March 04, 2015

News Daily News

MASTER: Potential Mortality Advantage With Mesh-Covered Stent in STEMI Patients at 1 Year

Yael L. Maxwell

February 19, 2015

News Daily News

MASTER: Posible Ventaja de la Mortalidad con Stents recubiertos con Malla en Pacientes STEMI al cabo de 1 Año

Yael L. Maxwell

February 19, 2015

News Daily News

MASTER：采用网膜支架在1年时可能会给STEMI患者带来益处

Yael L. Maxwell

February 19, 2015

News Daily News

Substudy Suggests Invasive Strategy Better for Elderly NSTE-ACS Patients

January 28, 2015

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2014

Caitlin E. Cox

January 12, 2015

News Daily News

Bigger Primary PCI Centers May Be Better, Danish Study Suggests

Yael L. Maxwell

December 28, 2014

News Conference News AHA 2014

AVOIDing Oxygen in Suspected STEMI Tied to Smaller Infarcts, Less Recurrent MI

Yael L. Maxwell

November 18, 2014

News Conference News AHA 2014

Registry: Newer P2Y12 Inhibitors Reduce Stent Thrombosis, Mortality Over Clopidogrel

Yael L. Maxwell

November 17, 2014

Presentation TCT 2014

Impact of Hospital vs_ Home call for Fellows and Cath Lab Team on Door to Balloon Times

Presenter: Luke Kohan

September 16, 2014

Presentation TCT 2014

Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes

Presenter: Kishore J. Harjai, Michael S. Lee

September 14, 2014

Presentation TCT 2014

STEMI Pharmacology: Ambulance, ER, Cath Lab, and CCU

Presenter: Luigi Salemme, Mohamed Sobhy

September 13, 2014

Presentation TCT 2014

Are GP IIb/IIIa Inhibitors Still Useful?

Presenter: Marco Valgimigli

September 13, 2014

Advertisement

Among Younger Patients, Women More Likely Than Men to Be Readmitted After Acute MI

Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients

Study Highlights Discrepancies in STEMI Recognition, Care Between Young Men, Women

Study Quantifies Costs Arising From Thrombotic Events During PCI for NSTE-ACS

BRIGHT Published: Prolonged Bivalirudin Reduces Bleeding, Tames Early Stent Thrombosis in Primary PCI

Public Reporting Linked to Less PCI, Higher Mortality in Acute MI Patients

MATRIX Provides Support for Radial Access, Mixed Results for Bivalirudin

VELOCITY Published: Peritoneal Cooling Does Not Decrease Infarct Size in STEMI

MASTER: Potential Mortality Advantage With Mesh-Covered Stent in STEMI Patients at 1 Year

MASTER: Posible Ventaja de la Mortalidad con Stents recubiertos con Malla en Pacientes STEMI al cabo de 1 Año

MASTER：采用网膜支架在1年时可能会给STEMI患者带来益处

Substudy Suggests Invasive Strategy Better for Elderly NSTE-ACS Patients

TCTMD’s Top 10 Most Popular News Stories for 2014

Bigger Primary PCI Centers May Be Better, Danish Study Suggests

AVOIDing Oxygen in Suspected STEMI Tied to Smaller Infarcts, Less Recurrent MI

Registry: Newer P2Y12 Inhibitors Reduce Stent Thrombosis, Mortality Over Clopidogrel

Impact of Hospital vs_ Home call for Fellows and Cath Lab Team on Door to Balloon Times

Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes

STEMI Pharmacology: Ambulance, ER, Cath Lab, and CCU

Are GP IIb/IIIa Inhibitors Still Useful?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content